NCT07122219 Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons
| NCT ID | NCT07122219 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
| Condition | HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 548 participants |
| Start Date | 2024-10-01 |
| Primary Completion | 2028-02-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 548 participants in total. It began in 2024-10-01 with a primary completion date of 2028-02-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.
Eligibility Criteria
Inclusion Criteria: * All people incarcerated at a study site during the intervention period Exclusion Criteria: \- None (site level intervention)
Contact & Investigator
Nadine Kronfli
PRINCIPAL INVESTIGATOR
Research Institute of the McGill University Health Centre
Frequently Asked Questions
Who can join the NCT07122219 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07122219 currently recruiting?
Yes, NCT07122219 is actively recruiting participants. Contact the research team at nadine.kronfli@mcgill.ca for enrollment information.
Where is the NCT07122219 trial being conducted?
This trial is being conducted at Edmonton, Canada, Abbotsford British Columbia, Canada, Mission, Canada, Dorchester, Canada and 5 additional locations.
Who is sponsoring the NCT07122219 clinical trial?
NCT07122219 is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. The principal investigator is Nadine Kronfli at Research Institute of the McGill University Health Centre. The trial plans to enroll 548 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.